2018 Scientific Advisory Board

 

 


The agenda is being shaped by an industry advisory board, with members including:

 

Professor Albert Osterhaus Professor Albert Osterhaus
Director, Research Center for Emerging Infections and Zoonoses (RIZ) 
University of Veterinary Medicine Hannover

Dr Jeffrey Almond Dr Jeffrey Almond
Former Vice President Discovery Research and Development, Sanofi and Visiting Professor  
University of Oxford - Oxford Vaccine Group

Dr Jan Poolman Dr Jan Poolman
Head Bacterial Vaccine Discovery and Early Development  
Janssen

Dr Gregory A. Poland Dr Gregory A. Poland 
Director of Mayo Vaccine Research Group  
Mayo Clinic and Foundation

Dr Antu Dey Dr Antu Dey
Senior Director, Research & Development  
International AIDS Vaccine Initiative

Konrad Stradler Dr Konrad Stradler
Head of R&D Vaccines  
Boehringer Ingelheim

Dr Roy Baynes Dr Roy Baynes
Senior Vice President Global Clinical Development and Chief Medical Officer  
MSD

Dr Nathalie Garçon Dr Nathalie Garçon 
CEO & CSO  
BIOASTER

Dr Cyril Gay   Dr Cyril Gay
Senior National Program Leader, Office of National Programs  
USDA

Dr Rino Rappuoli  Dr Rino Rappuoli
Chief Scientist  
GSK Vaccines

Dr Mahesh Kumar Dr Mahesh Kumar
Vice President, Global Biologics Research  
Zoetis

Dr Bernard Vallat Dr Bernard Vallat
Honorary Director General  
Office International Des Epizooties

Dr Ralf Clemens Dr Ralf Clemens
SVP
GRID Rio

Dr Jerald Sadoff Dr Jerald Sadoff 
Senior Advisor  
Janssen Infectious Diseases and Vaccines

Dr Lorne A. Babiuk Dr Lorne A. Babiuk
Former Vice-President
University of Alberta

Prof Roman Prymula Prof Roman Prymula
Professor Preventive Medicine
Charles University in Prague

Prof Hanna Nohynek Prof Hanna Nohynek 
Deputy Director
Finish Public Health

Prof Fred Zepp Prof Fred Zepp
Medical Director and Chairman of the Department of Paediatrics
University Medicine Mainz

Dr Annaliesa Anderson Dr Annaliesa Anderson
VP Bacterial Vaccines
Pfizer

Dr Joris Vandeputte Dr Joris Vandeputte
President 
IABS (International Alliance for Biological Standardization)

 

Prof Hanneke Schuitemaker Prof Hanneke Schuitemaker 
Global Head of Viral Vaccine Discovery and Translational Medicine in the Infectious Disease and Vaccines Therapeutic Area 
Janssen Vaccines

Dr Miles Carroll Dr Miles Carroll 
Deputy Director 
Public Health England

Dr Christiane Gerke, Head of Vaccine Programs, Institut Pasteur Dr Christiane Gerke
Head of Vaccine Programs
Institut Pasteur

 

 

 
 

APPLY TO SPEAK

 

 
 



If someone is interested in novel vaccine development approaches, this is definitely a great event for both scientists and business staff.


Business Development-Clinical Research SGS



 

Sign Up for Event Updates